Open AccessReal-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitors
Author(s) -
Derrek P. Hibar,
George D. Demetri,
Solange Peters,
Jessica Davies,
Olivier Humblet,
Sophia L. Maund,
Laura Mezquita Pérez
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0270571
Subject(s) - trk receptor , medicine , oncology , solid tumor , standard of care , bioinformatics , intensive care medicine , receptor , biology , cancer , neurotrophin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom